2006
DOI: 10.1291/hypres.29.105
|View full text |Cite
|
Sign up to set email alerts
|

Channel Blockers Reduce Angiotensin II-Induced Superoxide Generation and Inhibit Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Expression in Endothelial Cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
18
0
1

Year Published

2007
2007
2013
2013

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 25 publications
(19 citation statements)
references
References 39 publications
0
18
0
1
Order By: Relevance
“…En-Hui YAO 1) , Noboru FUKUDA 1), 2) , Taro MATSUMOTO 3) , Naohiko KOBAYASHI 4) , Mayumi KATAKAWA 1) , Chii YAMAMOTO 1) , Akiko TSUNEMI 1) , Ryo SUZUKI 1) , Takahiro UENO 1) …”
Section: Losartan Improves the Impaired Function Of Endothelial Progeunclassified
See 1 more Smart Citation
“…En-Hui YAO 1) , Noboru FUKUDA 1), 2) , Taro MATSUMOTO 3) , Naohiko KOBAYASHI 4) , Mayumi KATAKAWA 1) , Chii YAMAMOTO 1) , Akiko TSUNEMI 1) , Ryo SUZUKI 1) , Takahiro UENO 1) …”
Section: Losartan Improves the Impaired Function Of Endothelial Progeunclassified
“…In addition, unlike other antihypertensive drugs, ARBs are reported to have cardiovascular protective effects. The protective effects of ARBs with respect to vascular injury are associated with the inhibitions of Ang IIinduced vascular growth (1), extracellular matrix formation (2), and oxidative stress (3). Oxidative stress has emerged as a common theme of many conditions associated with shortened lifespan, including hypertension.…”
Section: Introductionmentioning
confidence: 99%
“…They also prevent Ang-II-induced increase in LOX-1. The salutary effects of calcium channel blockers in atherogenesis include the inhibition of the expression of LOX-1 (Toba et al 2006). LOX-1 gene polymorphisms also suggest the potential role of LOX-1 in cardiovascular diseases.…”
Section: The Effects Of Antiatherosclerotic Drugsmentioning
confidence: 99%
“…They also found that two nights of nCPAP therapy decreased ADM levels significantly (28). It has been recently postulated that an inflammatory process plays a crucial role in the pathogenesis of atherosclerosis, which in turn can lead to various cardiovascular disorders (29)(30)(31). In a previous study, we reported that the circulating intercellular adhesion molecule-1 (ICAM-1) level in patients with OSAS was significantly increased compared to that in the control group, suggesting that OSAS-induced hypoxia may induce the activation of ICAM-1 and the inflammation of the endothelium in patients with OSAS (8,9).…”
Section: Fig 5 Correlation Between Circulating Adm Levels and A: Spmentioning
confidence: 99%